Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for DGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 86.00M
March 31, 2026 -65.00M
December 31, 2025 282.00M
September 30, 2025 131.00M
June 30, 2025 -13.00M
March 31, 2025 -29.00M
December 31, 2024 130.00M
September 30, 2024 -24.00M
June 30, 2024 -16.00M
March 31, 2024 -12.00M
December 31, 2023 263.00M
September 30, 2023 -13.00M
June 30, 2023 -22.00M
March 31, 2023 -25.00M
December 31, 2022 434.00M
September 30, 2022 346.00M
June 30, 2022 142.00M
March 31, 2022 363.00M
December 31, 2021 268.00M
September 30, 2021 -40.00M
June 30, 2021 1.449B
March 31, 2021 393.00M
December 31, 2020 205.00M
September 30, 2020 -27.00M
June 30, 2020 -37.00M
Date Value
March 31, 2020 -5.00M
December 31, 2019 179.00M
September 30, 2019 18.00M
June 30, 2019 4.00M
March 31, 2019 33.00M
December 31, 2018 168.00M
September 30, 2018 76.00M
June 30, 2018 -37.00M
March 31, 2018 16.00M
December 31, 2017 110.00M
September 30, 2017 22.00M
June 30, 2017 99.00M
March 31, 2017 104.00M
December 31, 2016 140.00M
September 30, 2016 25.00M
June 30, 2016 244.00M
March 31, 2016 108.00M
December 31, 2015 48.00M
September 30, 2015 22.00M
June 30, 2015 19.00M
March 31, 2015 75.00M
December 31, 2014 27.00M
September 30, 2014 0.00
June 30, 2014 7.00M
March 31, 2014 20.00M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Labcorp Holdings, Inc. 352.00M
DaVita, Inc. 360.82M
OPKO Health, Inc. 13.36M
Psychemedics Corp. --
NeoGenomics, Inc. 21.64M